Quality of life improvement in a patient with severe atopic dermatitis treated with photopheresis

被引：31
|
作者：
Mohla, G [1 ]
Horvath, N [1 ]
Stevens, S [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Ireland Canc Ctr, Photopheresis Serv, Cleveland, OH USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1999年 / 40卷 / 05期
关键词：
D O I：
10.1016/S0190-9622(99)70167-2
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Atopic dermatitis is a common skin disease characterized by severely pruritic eczematous patches, papular and lichenified plaques, excoriations, cracks, and erosions. Photopheresis has been shown to ameliorate the signs and symptoms of atopic dermatitis in some patients. We describe successful results with photopheresis for refractory disease in a patient who chronicled his quality of life weekly for more than 15 years before and during extracorporeal photochemotherapy.
引用
收藏
页码：780 / 782
页数：3
相关论文
共 50 条
  • [41] Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
    Rial Prado, Manuel Jorge
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2018, 28 (06) : 420 - 421
  • [42] Improvement in severe nail disease in a patient treated with hand and foot dermatitis treated with Dupixent (dupilumab)
    Darch, Katherine
    Spelman, Lynda
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 73 - 73
  • [43] A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD)
    Whalley, D
    McKenna, SP
    Dewar, AL
    Erdman, RA
    Kohlmann, T
    Niero, M
    Cook, SA
    Crickx, B
    Herdman, MJ
    Frech, F
    Van Assche, D
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (02) : 274 - 283
  • [44] The cost of dupilumab treatment for severe atopic dermatitis is largely offset by broader health-care savings and improvement in quality of life
    Edwards, Harrison A.
    McMeniman, Erin K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2020, 61 (02) : E273 - E275
  • [45] Dupilumab improves signs, symptoms, and quality of life in adolescents with moderate to severe atopic dermatitis
    Eichenfield, Lawrence F.
    Silverberg, Jonathan I.
    Gadkari, Abhijit
    Guillemin, Isabelle
    Chen, Zhen
    Bansal, Ashish
    Eckert, Laurent
    Rosner, Karli
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB26 - AB26
  • [46] WORK ABILITY AND QUALITY OF WORKING LIFE IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Bosma, Angela L.
    Ouwerkerk, Wouter
    Gunal, Merve
    Hyseni, Arienna M.
    Arents, Bernd W. M.
    Gerbens, Louise A. A.
    Middelkamp-Hup, Maritza A.
    de Boer, Angela G. E. M.
    Spuls, Phyllis I.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 32 - 32
  • [47] Mogamulizumab in a patient with Sezary syndrome and severe atopic dermatitis
    Amatore, Florent
    Connell, Emily
    Aymonier, Marie
    Gaudy-Marqueste, Caroline
    Richard, Marie-Aleth
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S51 - S52
  • [48] Dupilumab and quality of life in adults with atopic dermatitis
    不详
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (03) : 479 - 479
  • [49] Quality of life in infants with atopic dermatitis and their families
    Djurovic, Milena Raznatovic
    Jankovic, Janko
    Cirkovic, Anda
    Spiric, Vesna Tomic
    Maksimovic, Natasa
    Timotijevic, Zorica Sojevic
    Vukicevic, Danica
    Mirkovic, Zlatica
    Vitkovic, Leonida
    Jankovic, Slavenka
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (01): : 66 - 72
  • [50] Adults with atopic dermatitis: Quality of life impact
    Taieb, C
    Marionneau, N
    Myon, E
    VALUE IN HEALTH, 2005, 8 (06) : A150 - A150
12345